AcclaimIP-ad

Match Document Document Title
DE69535316T2 ALS LERK6 designated CYTOKINE  
The invention is directed to LERK-6 as a purified and isolated protein, the DNA encoding the LERK-6, host cells transfected with cDNAs encoding LERK-6.
DE69233630T2 Rates of HIV probes for use in sandwich Hydridisierungsassays in solution phase  
Novel DNA probe sequences for detection of HIV in a sample in a solution phase sandwich hybridization assay are described. Amplified nucleic acid hybridization assays using the probes are exemplified.
DE60309345T2 INOSITOLDERIVATISIERTE PHOSPHOLIPIDS  
The present invention relates to a phospholipid derivative having a substituted or unsubstituted polyhydroxylated aliphatic carbocycle attached to the sn-1 or sn-2 position of the glycerol...
DE60215530T2 NEW glycolipid, AND REMEDIES FOR AUTOIMMUNE THIS IS AS ACTIVE INGREDIENT  
Glycolipid compounds (I) are new. Glycolipid compounds of formula (I) are new. [Image] R 1aldopyranose residue; R 2H or OH; R 3CH 2, CH(OH)CH 2 or CH=CH; R 4H or CH 3; x : 0-35; y+z : 0-3....
DE60124245T2 Uridine AS ANTIBIOTICS  
All possible isomeric forms of a compound of the formulawhere the substituents are defined as in the specification and its non-toxic, pharmaceutically acceptable salts useful as antibiotics.
DE69932926T2 GEN CODING FOR Labyrinthin, A CANCER MARKER  
A cDNA molecule that encodes a protein designated Labyrinthin (Lab) isolated and its nucleotide sequence is determined. The protein, or peptides derived from the protein, are markers useful to...
DE69932187T2 LINKS FOR CANCER THERAPY  
It is shown that the potency of anti-cancer drugs, here exemplified by doxorubicin, can be increased by the use of polyunsaturated fatty acid amides and in particular specific combinations of such...
DE69133545T2 A process for the preparation of specific binding pair members,  
A member of a specific binding pair (sbp) is identified by expressing DNA encoding a genetically diverse population of such sbp members in recombinant host cells in which the sbp members are...
DE60215315T2 USE OF FUSION PROTEINS WHOSE N-terminal part FROM A hirudin EXISTS FOR PRODUCING PROTEIN BY SECRETION BY YEASTS RECOMBINANT  
Nucleic acid sequence including: Px-Sx-Bn-(ZR)-Hir(AsmR)-protein(Y)-T. Px is a promoter sequence. Sx is a nucleic acid encoding a signal sequence or leader sequence. Bn is 1-15 codons, when n is...
DE60030965T2 CONJUGATES CONTAINING FISSILE TIE ONE ON THE APPLICATION in a liposome  
A compound comprised of a hydrophilic polymer covalently yet reversibly linked to a amine-containing ligand through a dithiobenzyl linkage is described.
DE69736476T2 IDENTIFICATION OF GENES IN MULTIPLE MYELOMA CHANGE ARE  
This invention provides a method of determining a chromosomal breakpoint in a subject suffering from multiple myeloma which comprises steps of: (a) obtaining a DNA sample from the subject...
DE19735868B4 Verfahren zur Herstellung gemischter Glucosaminsalze in einer therapeutisch wirksamen kristallinen Form  
Verfahren zur Herstellung einer therapeutisch wirksamen kristallinen Form von Glucosaminsulfat, die bei Umgebungstemperatur und -feuchtigkeit stabil ist und der empirischen Formel: entspricht, in...
DE69736239T2 MAGNETIC CELL SORTING ACTIVATED FOR THE PRODUCTION OF PROTEIN  
The invention includes methods of isolating DNA and a protein encoded thereby, the protein being capable of binding to an antigen-bearing moiety. The methods comprise generating a DNA library...
DE69736067T2 NEW cryptophycin derivatives as antineoplastic agents  
The invention provides novel cryptophycin compounds which can be useful for disrupting the microtubulin system, as anti-neoplastic agents, and for the treatment of cancer. The invention further...
DE60309514T2 Substances for the prevention and treatment of autoimmune diseases  
A substance is disclosed for preventing, delaying the onset of or treating one or more than one autoimmune disease, the substance comprising a combination of a polynucleotide construct comprising...
DE60212349T2 USE OF N-ACETYL-D-GLUCOSAMINE IN THE MANUFACTURE OF A PHARMACEUTICAL MEANS FOR THE PREVENTION AND TREATMENT OF SEXUAL DISORDERS  
The present invention has disclosed a use of N-acetyl-D-glucosamine in the preparation of a medicine for preventing and treating the sexual disfunction. The preparation taken...
DE60211632T2 Using Cyclotetrasaccharide to increase the "active oxygen eliminating activity"  
A reduction inhibitory agent for active oxygen eliminating activity which comprises cyclotetrasaccharide, i.e., cyclo{→6}-α -D-glucopyranosyl-(1 → 3)- α -D-glucopyranosyl-(1 → 6)- α...
DE60119534T2 USE OF hydroxyethylrutosides FOR THE TREATMENT OF COLD SYMPTOMS, SYMPTOM Allergic Rhinitis and RESPIRATORY INFECTIONS  
The present invention relates to methods of treating conditions and/or symptoms related to common cold of the upper and/or lower respiratory tract and/or eyes. In particular the invention relates...
DE60027905T2 Glycoconjugates, glycoamino acid, THEIR INTERMEDIATES, AND THEIR USE  
The present invention provides novel n-alkenyl glycosides and glycoconjugates, n-alkyl glycoamino acids, and methods for the synthesis thereof. In another aspect, the present invention provides...
DE69933287T2 12,13-MODIFIED Epothilone DERIVATIVES  
The present invention relates to 12,13-position modified epothilone derivatives, methods of preparation of the derivatives and intermediates therefor.
DE69931624T2 HEPARANASE SPECIFIC MOLECULAR PROBES AND THEIR USE IN RESEARCH AND MEDICAL APPLICATIONS  
A variety of heparanase specific molecular probes which can be used for research and medical applications including diagnosis and therapy. Specific applications include the use of a heparanase...
DE69931600T2 NEW GEN WITH A LAPEL Transcriptase-SCENE  
The present invention aims to provide a novel gene having a reverse transcriptase motif. The invention isolates a novel gene having a reverse transcriptase motif, and gives its complete base...
DE69931482T2 ISOLATED PEPTIDES amino acid sequences of NY-ESO-1 COMPLIANCE AND MHC CLASS I AND CLASS II MOLECULES MHC BINDING, AND USES THEREOF  
The invention relates to peptides which bind to MHC Class I and to MHC Class II molecules. These peptides are useful in different therapeutic and diagnostic contexts.
DE69834649T2 TIE LIGAND HOMOLOGUEN  
The present invention concerns isolated nucleic acid molecules encoding the TIE ligands NL1, NL5, NL8 and NL4, the protein encoded by such nucleic acid molecules, as well as methods and means for...
DE69636470T2 A aureobasidin sensitivity regulating gene  
A gene encoding a protein regulating aureobasidin sensitivity obtained from a mold belonging to the genus Aspergillus or its functional derivative. A cloning method with the use of at least a part...
DE69434744T2 POSITIVE SELECTION TO MANNOSE OR BASED xylose  
PCT No. PCT/EP94/00575 Sec. 371 Date Oct. 3, 1995 Sec. 102(e) Date Oct. 3, 1995 PCT Filed Feb. 28, 1994 PCT Pub. No. WO94/20627 PCT Pub. Date Sep. 15, 1994The present invention provides a method...
DE60309513T2 Substances for the prevention and treatment of autoimmune diseases  
A substance is disclosed for preventing, delaying the onset of or treating one or more than one autoimmune disease, the substance comprising a combination of a polynucleotide construct comprising...
DE60306190T2 2'-O-trisubstituted-Silyloxymethyl ribonucleoside DERIVATIVE AND METHOD FOR PRODUCING THE SAME  
The invention provides ribonucleoside derivatives with novel protecting groups and methods for the preparation of such ribonucleoside derivatives. The general formula (I) of the ribonucleoside...
DE60215461T2 SERPIN of bifidobacteria  
The present invention pertains to a novel microorganism of the genus Bifidobacterium longum, in particular to its genomic sequence and the nucleotide sequences encoding polypeptides of...
DE10333509B4 Directed against VEGF recognition molecules and the use of these  
Recognition molecule (I), directed against the gene for vascular endothelial growth factor (VEGF) is new. It interacts specifically with the mRNA of VEGF in the target sequence region 600-990 of M...
DE69934046T2 BETA-Glucooligosaccharides TO SPEED OF CALCIUM RECORDING  
Disclosed is a calcium assimilation accelerator which contains a beta -glucooligosaccharide as an active ingredient, a calcium-supplementing diet which contains a beta -glucooligosaccharide and a...
DE69933283T2 Photoactivatable NUCLEIC DERIVATIVES  
A photoactivatable nucleic acid derivative composition in which one or more photoreactive group(s) are bound to a natural or synthetic nucleic acid. The photoreactive groups can be bound to the...
DE69434750T2 INHIBITION OF GROWTH OF SELECTED TUMORS WITH RECOMBINANT VIRUS VECTORS  
The present invention provides methods for inhibiting the growth of selected tumors utilizing recombinant viral vectors. Briefly, within one aspect of the present invention, a method for...
DE60214889T2 SUCROSEOCTASULPHAT SILVER SALT  
The described invention relates to the new compound "sucrose-octasulphate salified with silver" usefully applicable in the prevention and cure of infections by micro-organisms of bacterial,...
DE60211227T2 Androgen receptor complex-associated protein  
The invention relates to new proteins that bind to and aid the transactivation activity of androgen receptors, and nucleic acids encoding them.
DE69930960T2 SYNTHETIC VIRUS-LIKE PARTICLES WITH HETEROLOGOUS EPITOPES.  
The invention is a series of synthetic virus-like particles comprising a heterologous conformational epitope useful in the characterization of human papillomavirus infection, and useful to...
DE69735995T2 OLIGOEPITOP PEPTIDE OF prostate-specific antigen  
The invention provides a prostate specific antigen oligo-epitope peptide (PSA-OP) that is useful as an immunogen in the prevention or treatment of prostatic cancer and in the inhibition of...
DE69636310T2 A process for producing a Raney catalyst  
To obtain a Raney catalyst for fixed bed permitting a continuous use with a high initial activity and to produce a high purity sugar-alcohol at a low cost using the same. For this object,...
DE69636216T2 COMPOSITIONS AND METHODS FOR TREATMENT AND DIAGNOSIS OF IMMUNE DISORDERS  
The present invention relates to methods and compositions for the treatment of immune disorders, especially T helper (TH) cell and TH cell-like related disorders. First, genes are identified and...
DE69334002T2 MEMBRANE ASSOCIATED PROTEINS OF IMMUNOGENIC MYCOBACTERIA  
Nucleic acid encoding four novel immunodeterminant protein antigens of M. bovis BCG, which is a vaccine strain for tuberculosis, have been isolated. These genes were isolated as immunoreactive...
DE602004001047T2 Phospholipid esters of clofarabine  
The subject of the present invention are specific lipidesters of halogenated-adenine nucleotides and the use of such lipidesters in the treatment of tumors.
DE60030847T2 ANTI INFECTIOUS macrolide derivatives  
Compounds of the formula wherein Ra is H; substituted or unsubstituted alkyl (1-10C); substituted or unsubstituted alkenyl (2-10C); substituted or unsubstituted alkynyl (2-10C); substituted or...
DE69836023T2 New formulation  
PCT No. PCT/SE98/01287 Sec. 371 Date Aug. 12, 1998 Sec. 102(e) Date Aug. 12, 1998 PCT Filed Jun. 29, 1998 PCT Pub. No. WO99/02542 PCT Pub. Date Jan. 21, 1999A pharmaceutical composition comprising...
DE69636232T2 Growth factor HTTER36  
The present invention discloses Growth Factor HTTER36 polypeptides and polynucleotides encoding such polypeptides. Also provided is a procedure for producing such polypeptides by recombinant...
DE60124030T2 Treatment of rumen acidosis with Amylasehemmern  
Inhibitors of rumen bacterial alpha-amylase and/or alpha-glucosidase are useful in the preparation of medicaments for the curative, palliative and prophylactic treatment of rumen acidosis and...
DE60123042T2 L-FMAU FOR THE TREATMENT OF HEPATITIS DELTA VIRUS infection  
A method for the treatment for hepatitis delta infection in a host, that includes administering an effective amount of a nucleoside or a nucleoside analog that suppresses the expression of the...
DE60027039T2 Cisplatin and other drugs or genes encapsulated in liposomes for human cancer therapy  
A method for encapsulating cisplatin and other positively-charged drugs into liposomes having a different lipid composition between their inner and outer membrane bilayers is disclosed. The...
DE19900681B4 Using Anionaustauschermembranen for the removal of endotoxins from solutions containing nucleic acid  
use microporous weak basic Anionaustauschermembranen type Sartobind® D in a Anion exchange chromatography for the removal of endotoxins from Nucleic acid-containing Solutions.
DE102005046361A1 Detection and differentiation of Salmonella serovars, especially parathyphi B and Java, useful for analysis of e.g. food, clinical and water samples, based on amplification of gene STM3356  
Method for detecting and/or differentiating Salmonella serovars (A). Method for detecting and/or differentiating Salmonella serovars (A) comprises (i) amplifying a region of the STM3356 gene,...
DE60304678T2 Idraparinux (SanOrg 34006) FOR THE TREATMENT AND SECONDARY PREVENTION OF THROMBOEMBOLISM IN PATIENTS WITH DEEP VEIN THROMBOSIS  
The invention relates to a dose of 2.5 mg of the pentasaccharide methyl O-(2,3,4-tri-O-methyl-6-O-sulfo-α-D-glucopyranosyl)-(1→4)-O- (2,3-di-O-methyl-β-D-glucopyranosyl uronic...